ArticleJournal of immunology (Baltimore, Md. : 1950)2016

Cutting Edge: Engineering Active IKKβ in T Cells Drives Tumor Rejection.

César Evaristo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.